• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.82% Nasdaq Up2.46%

    Peregrine Pharmaceuticals, Inc. (PPHM)

    -NasdaqCM
    1.21 Up 0.06(5.22%) Sep 2, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingApr 30, 2015Jan 31, 2015Oct 31, 2014Jul 31, 2014
    Total Revenue 9,308   5,677   6,300   5,496  
    Cost of Revenue4,758  3,113  4,139  3,583  
    Gross Profit 4,550   2,564   2,161   1,913  
    Operating Expenses
    Research Development11,531  11,261  10,003  10,201  
    Selling General and Administrative5,188  4,325  4,295  4,883  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (12,169) (13,022) (12,137) (13,171)
    Income from Continuing Operations
    Total Other Income/Expenses Net34  29  37  42  
    Earnings Before Interest And Taxes(12,135)(12,993)(12,100)(13,129)
    Interest Expense -  1   -   -  
    Income Before Tax(12,135)(12,994)(12,100)(13,129)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(12,135)(12,994)(12,100)(13,129)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (12,135) (12,994) (12,100) (13,129)
    Preferred Stock And Other Adjustments(1,119)(775)(774)(1,028)
    Net Income Applicable To Common Shares (13,254) (13,769) (12,874) (14,157)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.